Abattis Bioceuticals Corp. (ATTBF)

[guay]

The country’s research around cannabis is booming and it’s expected to have long-term impact on everything from farming to new medicine.

Initial research has led to more and more need for data and is driving massive investment, most of it coming by way of the companies leading the charge to produce medicinal and recreational pot.

Some of the first-movers have also incorporated research and laboratory testing as a part of their integrated approach to developing cannabis operations. Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF), based in western Canada, has been gathering momentum by incorporating research, Health Canada approved licensed testing and extraction development. Abattis is right on the leading edge.

https://www.baystreet.ca/stockstowatch/2515/Cannabis-Research-Booms-with-Backing-of-Commercial-Growers